Vous êtes ici

Willow Biosciences Inc.

Liste d'échange: 
CSE
Statut: 
Delisted
Industrie: 
Life Sciences
Symbole: 
WLLW
Indice CSE: 
Devise: 

Willow Biosciences are pioneers in the biotechnology sector and have developed the only fully-integrated synthetic biology solution for opioid biosynthesis. We are now leveraging our unique design-build process to the biosynthesis of cannabinoids.

Vous êtes ici

Willow Biosciences Inc. (WLLW)

SEDAR Information

Information d'entreprise

Addresse
3655 36th Street NW
Calgary, AB T2L 1Y8
Canada
Téléphone
403-669-4848
Fax
1-587-779-6149
Courriel
info@willowbio.com
URL
http://www.willowbio.com
Date d’inscription à la cote
Jeudi, septembre 14, 2017
Agent de transfert
Alliance Trust Company
Vérificateur
KPMG LLP

Advertisement

Publicité

Capitalisation

Capitalisation: 
78,891,879
Réservé à l'émission: 
33,524,529

Company Officers

Trevor Peters, President and Chief Executive Officer
Travis Doupe, Chief Financial Officer
Peter Facchini, Chief Scientific Officer
Jerry Ericsson, Vice President, Operations
Jill Hagel, Vice President, Applied Science
Mathias Schuetz, Vice President, Research and Development
Troy Talkkari, Vice President, Corporate Development
Joseph Tucker, Executive Chairman

Bulletins

Advertisement

Publicité

Latest CSE News

Évènements à venir

Website_2.jpg

Capital Markets Comeback Tour

Mercredi, mai 11, 2022 (Jour entier) - Jeudi, juin 2, 2022 (Jour entier)
VRIC_1200x675.jpg

Vancouver Resource Investment Conference (VRIC)

Mardi, mai 17, 2022 - 08:30 - Mercredi, mai 18, 2022 - 17:30